Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. - Prakoso, Emilia; Strasser, Simone I.; Koorey, David J.; Verran, Deborah; McCaughan, Geoffrey W. (Clinical Transplantation, 2006)